Boston, MA 02\/26\/2014 (wallstreetpr) – Nokia Corporation (ADR) (NYSE:NOK)<\/b> eventually put rumors to rest, but somehow learnt that it can be very difficult to place a tight lid on what you are cooking in the tech industry. The devices which the company announced were not far from the rumors that had already hit the streets long before the official announcement. Away with rumors, the new Nokia devices, the X family, if you like, have another street name \u201cWindroids.\u201d That the phones run on a forked version of Android but able to utilized Windows and Nokia resources makes the street name apt. The Windroids, officially known as Nokia X, X+ and XL will be immediately available in many markets across the world, more so the emerging markets are they are low-cost devices. Nokia Corporation (ADR) (NYSE:NOK) announced starting price of $122 for the devices.<\/p>\n
<\/p>\n
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) <\/b>announced in its fiscal 2013 fourth quarter that loss expanded to more than $74 million, reflecting per share loss of 40 cents. In the same quarter of 2012, ARIA witnessed loss of roughly $60 million, meaning 36 cents per share. The noted increase in net loss in the latest quarter was mainly due to the operating expenses which hit $21.6 million. Other sources of loss in the fourth quarter were commercialization of its new cancer drug Iclusig and the development and marketing of its various products, including continued research on drug candidates. However, the fourth quarter loss would have been really huge had it not been for the strong sales of Iclusig. Analysts on their part had expected that ARIA would come with a loss of 47 cents per share. Revenue in the quarter came in at $8.35 million, ahead of the expected $6.31 million. The stock of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was last seen gaining 0.46 percent to $8.67.<\/p>\n
Inovio Pharmaceuticals Inc (NYSEMKT:INO) <\/b>was last seen as an active mover, trading heavy stock volume and falling by more than 4.3 percent to touch $3.56 per share. More than three times the average daily volume of INO stock changed hands in the previous session. It was a day that the share of INO escalated to $3.93 and bottomed at $3.53. The day\u2019s highest boundary was just 2 cents shy of catching up with the 52-week top level at $3.95.<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 02\/26\/2014 (wallstreetpr) – Nokia Corporation (ADR) (NYSE:NOK) eventually put rumors to rest, but somehow learnt that it can be very difficult to place […]<\/p>\n","protected":false},"author":10,"featured_media":15439,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264,263],"tags":[3360,3361,2981,2781,2817,672,2982],"stock_ticker":[],"class_list":["post-16024","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-technology","tag-ariad-pharmaceuticals","tag-inc-nasdaqaria","tag-inovio-pharmaceuticals-inc-nysemktino","tag-nasdaqaria","tag-nokia-corporation-adr-nysenok","tag-nysenok","tag-nysemktino","entry"],"acf":[],"yoast_head":"\n